Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-700
Closed -$207K 139
2025
Q4
$207K Buy
+700
New +$210K 0.06% 129
2025
Q3
Sell
-744
Closed -$219K 138
2025
Q2
$219K Buy
+744
New +$192K 0.07% 121
2020
Q4
Sell
-1,806
Closed -$211K 122
2020
Q3
$211K Buy
1,806
+1
+0.1% +$118 0.1% 97
2020
Q2
$208K Buy
+1,805
New +$210K 0.11% 96
2020
Q1
Sell
-1,727
Closed -$221K 106
2019
Q4
$221K Sell
1,727
-1,004
-37% -$130K 0.11% 98
2019
Q3
$380K Buy
2,731
+879
+47% +$119K 0.2% 84
2019
Q2
$244K Hold
1,852
0.13% 98
2019
Q1
$250K Buy
+1,852
New +$236K 0.13% 97

Other funds holding IBM

O'Brien Greene & Co's IBM Position: Q1 2026 in Review

O'Brien Greene & Co sold out of IBM (IBM) in Q1 2026, closing a stake of 700 shares — an estimated $207K sold.

O'Brien Greene & Co first reported a position in IBM in Q1 2019 and held it in 8 quarters. The position peaked at $380K in Q3 2019. 3,462 funds tracked by Wall St. Rank hold IBM as of Q1 2026.

  • O'Brien Greene & Co reported no remaining IBM position as of Q1 2026 after selling out during the quarter.
  • O'Brien Greene & Co sold 700 IBM shares in Q1 2026, an estimated $207K.
  • O'Brien Greene & Co first reported a position in IBM in Q1 2019 and held it in 8 quarters.
  • O'Brien Greene & Co's IBM position peaked at $380K in Q3 2019.
  • 3,462 funds tracked by Wall St. Rank held IBM as of Q1 2026.

Based on O'Brien Greene & Co's 13F filing for Q1 2026, filed 6 May 2026.